show episodes
 
On November 2, 2016 The "Take It Personal" Podcast was launched as the Golden Era and boom-bap-focused podcast to beat all Podcasts. Broadcasting all the way live from Del Boca Vista and brought to you by the Philaflava crew, who founded one of Complex Magazine's "Top 10 Most Influential Hip-Hop Message Boards," well as authoritative subject matter blogs, T.R.O.Y and "Steady Bloggin'," the show and its brand of witty nuance and authentic reverence courtesy of co-hosts Jason Gloss, Kevlar, DJ ...
  continue reading
 
We've been fans of Marvel comics since we were little kids, and shows like Loki, What If...?, and Moon Knight make us feel like kids again! Join us as we break down each episode with a good balance of fun and getting into the details to connect the dots of this grand story. We're Podcastica, and we've been doing episode-by-episode deep dives into amazing TV shows for over a decade now. Check out our other fare at Podcastica.com. For all time, always.
  continue reading
 
Artwork

1
The Paddlefish Caviar Heist

Imperative Entertainment and Vespucci

Unsubscribe
Unsubscribe
Monthly
 
"Best True Crime Podcast" Nominee, 2023 Ambies Warsaw, Missouri, is a small, rural town of just over 2,000 people in the American Midwest. Locally it’s known as the “quiet end of the Lake of the Ozarks.” Very few realize that it’s the paddlefish capital of the world. But when a new group arrived driving flashy, imported cars and dropping hundreds of dollars on bait and tackle, the town became the setting for an undercover federal sting operation tasked with bringing down a suspected internat ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Jared Goetz is a 32-year-old modern-day entrepreneur who has shifted focus from building eCommerce empires to building inner empires. Having gone through the attainment of material gains, and seeing patterns, Jared realized that the route to fulfillment is through inner game and spirituality. The ZenHard podcast aims to bring knowledge of the best minds in the world to the everyday listener on topics regarding meditation, mindset, routines, goal-setting, biohacking, nutrition, mental health, ...
  continue reading
 
Artwork

1
The B2B Revenue Executive Experience

Carlos Nouche & Lisa Schnare - Mentors in Revenue optimization and Sales Development

Unsubscribe
Unsubscribe
Weekly
 
The B2B Revenue Executive Experience is a podcast hosted by Carlos Nouche and Lisa Schnare who dedicate each episode to helping executives train their sales and marketing teams to optimize growth. Whether you’re interested in increasing margins and growing your market share, enabling your teams to compete on value rather than price, hiring new employees, or trying to stay at the forefront of the latest in sales and marketing techniques, this podcast will give you the tools and skills necessa ...
  continue reading
 
Loading …
show series
 
So many companies start out with the goal of going public and hitting it big. But, unfortunately, for many of them, a successful exit via a merger or purchase is far more likely. We wondered: What are the best strategies to position your company as the go-to-market leader during an M&A process? To help us with this today, we have Aron Bohlig, Manag…
  continue reading
 
We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…
  continue reading
 
On episode 149, we're honoring this 1993 musical masterpiece. This classic ATCQ album embodies everything that made us me fall in love with hip-hop. It was pure perfection. An absolute game changer and the album that helped usher in the 2nd golden era. Like what we’ve recently done with Paul’s Boutique, we strip this album completely and build it b…
  continue reading
 
When you do something innovative and extraordinary, you go from 0 to 1. While you might not become the next Apple or Amazon, we decided to gather the top insights to take your business to the next level. So, we asked: What are some of the most effective go-to-market strategies for startups going from early days to scaling up their business? To help…
  continue reading
 
Pharoahe Monch stopped by to discuss his concert at Lincoln Center in NYC, to celebrate the 25-Anniversary of his classic, Internal Affairs. Special guests include M.O.P., Large Professor, Talib Kweli, Styles & Prince Po, so you're not going to want to miss this show. Pharoahe talks about his upcoming Roc Nation album, External Affairs. We get into…
  continue reading
 
We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…
  continue reading
 
Revenue growth is a key priority for organizations. Now, let's say you're taking over a revenue team. Where do you start? Or, in other words... How should a new revenue leader inheriting an existing team with predefined goals determine what that revenue engine should look like, from hiring to structure and processes? To help us with this today, we …
  continue reading
 
We love to hear from our listeners. Send us a message. Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's three phase 1 programs combine T-cell science with a proprietary drug delivery device to target solid tumors, specifically metastatic breast, non-small-cell lung, and castrate-resistant prostate cancers. …
  continue reading
 
Organizations are constantly seeking ways to increase their revenue and achieve sustainable growth. However, scaling revenue requires a strategic approach that goes beyond traditional sales tactics. Therefore, we wanted to find out: What are the top sales strategies for effectively scaling your revenue? To help us with this today, we have Greg Nutt…
  continue reading
 
We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…
  continue reading
 
On episode 148, we've got a bunch of new(er) music on deck like Rakim, Common & Pete Rock, Madlib, Conway The Machine, Chuck Strangers, Supastition, 2Mex, Fashawn, Apathy, Mach-Hommy, Your Old Droog, Brother Ali, General Steele, Crimeapple & Big Ghost Ltd, Rome Streetz, Da Beatminerz, Spice 1, Marv Won, Slum Village, Roc Marciano and Tha Dogg Pound…
  continue reading
 
Have you ever dreamt of starting a global company but are unsure where to begin? Or maybe you're struggling to keep your remote team connected and productive. The question is: How do you launch a successful startup, target the perfect niche market, and navigate the complexities of remote work without losing the human touch? To help us with this tod…
  continue reading
 
We love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns that kept a largely aged patient population from setting fo…
  continue reading
 
Sales is hard right now. Sales cycles have lengthened by 40% since 2020. Fewer reps are achieving their quota in tech. So the question is: What are some strategies to help you stand out from the crowd? To give us some insight into this question, we have Jason Bay, Founder and CEO of Outbound Squad, who aims to improve the skills of world-class sale…
  continue reading
 
We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …
  continue reading
 
Winning in sales today requires more than persuasive skills and product knowledge to succeed. Experienced businesses have learned this the hard way. But what if you're just at the beginning of your sales journey? If you were to establish a sales organization from the ground up, what beliefs, mindset, and behaviors would create a customer-first cult…
  continue reading
 
We love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the back of an MIT Ph.D. in biological engineering, having co-f…
  continue reading
 
Sales is a high-pressure job that often involves stepping out of your comfort zone and facing imposter syndrome. To thrive, you need to develop a strong emotional muscle. The question is: How does emotional fitness relate to our performance under pressure and our long-term resilience in sales? To help us with this today, we have Ben Drakes, Founder…
  continue reading
 
We love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership …
  continue reading
 
On episode 147, we're turning up the BPMs for some head smashers. You're going to call Safelite for a new windshield after this episode. We've got bangers from Ghostface Killah, M.O.P, Nature, Smif N Wessun, Pete Rock, Juggaknots, Ras Kass, Non Phixon, Cali Agents, Darc Mind and Vakill.At the break, we discuss freestyle rappers. That's right, we ta…
  continue reading
 
Traditionally, sales and marketing have operated independently, often resulting in miscommunication, wasted resources, and missed opportunities. But things start changing with a little help from AI. How can generative AI align B2B marketing and sales teams for revenue growth in 2024? To help us with this today, we have Nathan Schlaffer, CEO and Fou…
  continue reading
 
We love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, …
  continue reading
 
Customer success and product marketing can be the driving force behind any go-to-market strategy. However, the entire organization must work together to achieve success and deliver measurable results. With that in mind, we wanted to know: How can you successfully align product, marketing, sales, and customer success for a winning go-to-market strat…
  continue reading
 
We love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contract developer, CTMC began with a more fundamental mission…
  continue reading
 
On episode 146 we're bringing you vibes and stuff. After giving you nothing but tributes all year, we're pivoting to an episode of just lounging. We've got music from The Mighty Mos Def, Aceyalone, People Under The Stairs, Hieroglyphics, Blackalicious, Atmosphere, J-Live, Common, Redman, Jay Electronica, Common and A Tribe Called Quest to name a fe…
  continue reading
 
Today, success in B2B sales doesn't come easy and goes way beyond a simple pitch and a few cold calls. B2B sales require a more strategic and personalized approach. However, it's all about setting a strong foundation. Here's the main question: Why should you understand the problems your company solves when building an ideal customer profile and pip…
  continue reading
 
We love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current …
  continue reading
 
Marketing and sales - a powerful combination that can make or break your entire business. The key word here is alignment between those two. Creating an effective collaborative space is more than just asking both parties to work together; it requires defined steps toward cooperation. Let's start with a simple question in mind: Why should you build a…
  continue reading
 
Episode 145 is something DJ 360 has dreamed about doing since 1989. To tackle the brilliance behind Paul's Boutique is no easy feat but on this episode you'll hear each track being reproduced with original samples, both original and new production all to breath new life into this 35 year old masterpiece. Side A To All the Girls Shake Your Rump John…
  continue reading
 
We love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a …
  continue reading
 
“When you love something, you protect it. It is the most natural thing in the world.” Karen, Renaldy and Penny invite you to take a fresh look at 2021’s ETERNALS. They highlight the many ways the film breaks the mold for the MCU, introducing a scope that stretches the edges of the multiverse as we know it and delivering a distinctive style and brea…
  continue reading
 
The evolution of the buyer-seller journey is a never-ending story between the two sides. However, in the last 5 years, the changes have been remarkable. We wanted to find out: How are changes in buyer-seller dynamics causing friction in the sales process? To help us with this today, we have Greg Brown, Managing Partner at ValueSelling Associates. G…
  continue reading
 
We love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to …
  continue reading
 
Imagine a Venn diagram where leadership's vision overlaps with the practicalities of product marketing, the product team, and customer feedback. That is sales enablement. Sales enablement has become an integral part of every successful organization. So then, we asked ourselves: How can you effectively integrate sales enablement with your sales stra…
  continue reading
 
We love to hear from our listeners. Send us a message. Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital eve…
  continue reading
 
Episode 144 is our final installment of our 2-part Little Brother tribute. We're finishing up this homage with your favorites from their illustrious catalog, as well as the compilations, mixtapes and other dope collabos. Our exclusive interview with Phonte and Rapper Big Pooh is now streaming on all platforms. Be sure to check out our new items in …
  continue reading
 
Many startups get their Ideal Customer Profile (ICP) wrong. The results? Low-quality leads, decreasing revenues, and unhappy customers. It's time to fix that. How can you identify your ICP to achieve higher win rates, lower cost of acquisition, and better customer retention? To help us with this today, we have Eric Holmen, Former CEO of Splash. Eri…
  continue reading
 
We love to hear from our listeners. Send us a message. This episode of the Business of Biotech begins with a personal story about my dad and the standard of care in bladder cancer, before shifting to the work that Dr. Bobby Reddy and his team at ImmunityBio are doing to change that standard of care. They're painfully close. Dr. Reddy, Chief Medical…
  continue reading
 
Sales training plays a key role in the success of any business. It equips sales professionals with the necessary skills and knowledge to effectively engage with customers and close deals. If you're one of them, you've probably gone through sales training programs that start strong, but within weeks or months, they often lose momentum and fail to pr…
  continue reading
 
We love to hear from our listeners. Send us a message. Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with th…
  continue reading
 
It used to be so easy to hire a professional with hundreds of CVs flooding your inbox. But the game has changed, and to become the best, you need the best. Technology has changed the rules, and that's where the problem lies. Well then, we have a big question: How can you shed some of your limited beliefs when it comes to hiring criteria and moderni…
  continue reading
 
We love to hear from our listeners. Send us a message. We've really been looking forward to dropping this episode with Karen Harris, Chief Financial Officer and Head of Mission-Related Investing at the Alzheimer's Drug Discovery Foundation. While the markets have warmed a bit since we recorded this episode, Karen's thoughtful perspective on the som…
  continue reading
 
Episode 143 is part 1 of our Little Brother tribute. We're deep diving in their catalog and hitting you with your favorites, the collabos, the bootlegs and b-sides, the mixtape joints and both Pooh and Phonte's solo work. Our exclusive interview with Phonte and Rapper Big Pooh is now streaming on all platforms. Be sure to check out our new items in…
  continue reading
 
The RevOps function has changed tremendously fast. What was relevant yesterday doesn't work today anymore. Well then, a logical question emerges: Considering the evolution of RevOps over the past several years, where is the industry heading, and what are the lessons learned from building a global RevOps community? To help us with this today, we hav…
  continue reading
 
We love to hear from our listeners. Send us a message. Few drug discovery and development concepts are as hyped, and as such, draw as much polarity from drug developers, as machine learning and artifical intelligence. One company on the bullish end of the spectrum is Flagship Pioneering's Generate Biomedicines, which bills itself at the "intersecti…
  continue reading
 
Loading …

Quick Reference Guide